miR-708-5p is elevated in bipolar patients and can induce mood disorder-associated behavior in mice

Carlotta Gilardi1, Helena C Martins1, Brunno Rocha Levone1

  • 1Laboratory of Systems Neuroscience, Institute for Neuroscience, Department of Health Science and Technology, ETH Zurich, 8057, Zurich, Switzerland.

EMBO Reports
|March 11, 2025
PubMed

Insights

MicroRNA miR-708-5p is elevated in individuals predisposed to mood disorders (MDs) and in patients diagnosed with MDs. This microRNA targets Neuronatin (Nnat), suggesting a role in MD etiology and diagnosis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mood disorders result from complex genetic and environmental interactions.
  • Molecular mechanisms underlying mood disorder risk are not fully understood.

Purpose of the Study:

  • Investigate the role of microRNA miR-708-5p in mood disorder (MD) etiology.
  • Identify miR-708-5p as a potential diagnostic biomarker for MDs.

Main Methods:

  • Small-RNA sequencing in peripheral blood mononuclear cells (PBMCs).
  • In vivo studies using rat and mouse models of early life stress and mood disorder endophenotypes.
  • Direct targeting and rescue experiments involving miR-708-5p and Neuronatin (Nnat).

Main Results:

  • miR-708-5p is upregulated in individuals with high genetic/environmental risk for MDs and in MD patients.
  • Hippocampal miR-708-5p overexpression induces MD-associated behaviors in mice.
  • miR-708-5p directly targets Nnat; Nnat restoration rescues behavioral deficits.
  • Peripheral miR-708-5p differentiates bipolar disorder (BD) from major depressive disorder (MDD) patients.

Conclusions:

  • The miR-708-5p/Nnat pathway is implicated in mood disorder pathogenesis.
  • Peripheral miR-708-5p shows potential as a biomarker for differential diagnosis of mood disorders.